- Home
- PENG vs HTFL Comparison
PENG vs HTFL Comparison
Compare PENG & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PENG | HTFL |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PENG | HTFL |
|---|---|---|
| Price | $43.85 | $54.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $85.63 | $50.50 |
| AVG Volume (30 Days) | ★ 3.4M | 1.5M |
| Earning Date | 10-06-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 828.57 | 82.37 |
| EPS | ★ 2.60 | N/A |
| Revenue | ★ $1,731,468,000.00 | $176,034,000.00 |
| Revenue This Year | $41.70 | $41.24 |
| Revenue Next Year | $12.27 | $24.11 |
| P/E Ratio | $17.62 | ★ N/A |
| Revenue Growth | 26.50 | ★ 39.92 |
| 52 Week Low | $16.04 | $20.13 |
| 52 Week High | $89.86 | $60.56 |
Technical Indicators
Market Signals| Indicator | PENG | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 52.37 |
| Support Level | $16.72 | $46.46 |
| Resistance Level | $54.55 | $60.56 |
| Average True Range (ATR) | 4.79 | 3.17 |
| MACD | -1.57 | -0.50 |
| Stochastic Oscillator | 27.73 | 39.79 |
Price Performance
Historical ComparisonAbout PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.